^
    5ms
    NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care (NeoGenomics Press Release)
    "NeoGenomics, Inc...today announced the launch of PanTracer™ Tissue, a next-generation solid tumor profiling assay, including the option to add testing for homologous recombination deficiency (HRD). These new options can provide faster, actionable insights to help physicians navigate complex treatment decisions more confidently."
    Launch
    |
    PanTracer LBx™ Assay • PanTracer™ Tissue + HRD